Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited - pharma in Vadodara, Gujarat, India. FY 2026 financials & compliance.
CIN U24231GJ1994PLC022787 Incorporated 17 August 1994 ROC Ahmedabad HQ Vadodara, Gujarat, India
Active Public Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹120.09 Cr
▼ 4% YoY
Net profit · FY 2025
₹12.61 Cr
Net margin 10.5%
EBITDA · FY 2025
₹19.28 Cr
EBITDA margin 16.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.38 Cr
Issued & subscribed
Open charges
₹6.8 Lakh
Satisfied ₹9.3 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
780
Provident fund records

About Shine Pharmaceuticals Limited

Data last updated:

Shine Pharmaceuticals Limited is a public limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1994PLC022787. Its GSTIN is 24AAECS2660M1Z7 (Gujarat). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.38 Cr. It was formerly known as Shine Pharmaceuticals Private Limited. It is led by directors including Samir Chakraborty (Managing Director) and Aloka Saha (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vadodara, Gujarat.

As per the financials filed for FY 2025, the company reported a revenue of ₹120.09 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹12.61 Cr (net margin 10.5%) and EBITDA of ₹19.28 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.

The company has about 780 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Shine Pharmaceuticals. As per MCA filings, the company has open charges of ₹6.8 Lakh and satisfied charges of ₹9.3 Cr on record. Court records list 14 cases involving the company, including 5 filed by the company and 9 filed against it; 7 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in August 2019. Its 5 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 4 smaller; the largest is Aurochem Laboratories (India) Private Limited with revenue of ₹121.52 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 48 overdue payments to 48 micro and small suppliers.

Shine Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0074140). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shinepharma.com.

Company details

CIN U24231GJ1994PLC022787
Registration Number 022787
Incorporation Date 17 August 1994
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0074140

CIN history

Shine Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231GJ1994PTC022787. The current CIN is U24231GJ1994PLC022787, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231GJ1994PLC022787Current
U24231GJ1994PTC022787Previous
Key People
Samir Chakraborty Managing Director Aloka Saha Whole-Time Director Pradeep Vishambhar Agrawal Whole-Time Director

Recognitions & Rankings of Shine Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-24-0074140

Contact details

Shine Pharmaceuticals Limited's registered office is in Vadodara, Gujarat. Its website is shinepharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    shinepharma.com
  • Social Media
  • Registered Address
    309 – 310 Dwarkesh Complex 3rd Floor Sun Pharma Road Off. Old Padra Road At, Ladara, Vadodara, Gujarat, India – 390012
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Shine Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Shine Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Shine Pharmaceuticals operates one associated brand: Shine Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Shine Pharmaceuticals
Specialty pharmaceutical company producing formulations for psychiatry, cardiology, and gastroenterology.shinepharma.com

Business activity

The main business activity of Shine Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Shine Pharmaceuticals Limited, buy the company report.

Financials of Shine Pharmaceuticals Limited

FY 2025 filings available

Shine Pharmaceuticals Limited reported revenue of ₹120.09 Cr (down 4% YoY) for FY 2025.

Revenue · FY 2025
₹120.09 Cr ▼ 4%
Net profit · FY 2025
₹12.61 Cr margin 10.5%
EBITDA · FY 2025
₹19.28 Cr margin 16.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 2%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 10%
5 years · compounded
▲ 13%

Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹19.28 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹12.61 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin16.1%
Net Profit Margin10.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Shine Pharmaceuticals Limited, buy the company report.

Board of directors of Shine Pharmaceuticals Limited

Shine Pharmaceuticals has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Tejal Ashish Parikh
Also directs: Mew Electricals Limited
Director30 Mar 20242 Years 7 MonthsCurrent
Hiranmay SahaDirector30 May 199630 Years 5 MonthsCurrent
Samir Chakraborty
Also directs: Vital Care Pvt Ltd, Interpharm Biotech Private Limited, Bhoomi Medicaments Limited
Managing Director01 Apr 200521 Years 7 MonthsCurrent
Rangoli Saurav Gada
Also directs: Link Pharmachem Limited, Medicap Healthcare Limited
Director25 Mar 20233 Years 7 MonthsCurrent
Aloka SahaWhole-Time Director30 May 199630 Years 5 MonthsCurrent
Pradeep Vishambhar Agrawal
Also directs: Vital Care Pvt Ltd, Interpharm Biotech Private Limited, Bhoomi Medicaments Limited and 3 more
Whole-Time Director01 Jul 200323 Years 4 MonthsCurrent
View all directors

Peer comparison

Shine Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aurochem Laboratories (India) Private Limited₹121.52 Cr (FY 2024)4.0%Mumbai, Maharashtra, India
Shine Pharmaceuticals Limitedthis company₹120.09 Cr (FY 2025)₹12.61 Cr10.5%-4.0%780Vadodara, Gujarat, India
Vartika Chemicals & Pharmaceuticals Private Limited₹120.07 Cr (FY 2025)-17.0%New Delhi, Delhi, India
Ananta Medicare Limited₹120.04 Cr (FY 2025)50.0%Delhi, India
Amol Pharmaceuticals Private Limited₹119.9 Cr (FY 2025)5.0%Jaipur, Rajasthan, India
Alvita Pharma Private Limited₹119.83 Cr (FY 2024)7.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Shine Pharmaceuticals Limited, buy the company report.

Auditor

Shine Pharmaceuticals Limited is audited by Shah Sanghvi & Co for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Shah Sanghvi & CoFY 2024109794W

Shareholding

The shareholding of Shine Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Shine Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹6.8 Lakh
Satisfied charges
₹9.3 Cr
Breakdown by lending institutions
Axis Bank Limited₹0.07 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Jun 2019100272741Axis Bank Limited₹6.8 LakhOpen
24 Dec 2020100397788Others₹2 CrSatisfied
26 Sep 2019100294266Others₹75 LakhSatisfied
03 Jan 200480036721Bank of Baroda₹3.55 CrSatisfied
05 Jul 200380036720Bank of Baroda₹3 CrSatisfied

To see the full charge records of Shine Pharmaceuticals Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Shine Pharmaceuticals Limited has 2 deals on record (2 secondary share transfers); the latest was in August 2019.

Total deals
2
Secondary share transfers
2

Deals on record (2 of 2)

WhenDealAmountParties
Aug 2019Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Jun 2018Secondary share transferUndisclosedBuyer: Pradeep V Agrawal HUF, 2 individuals
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Shine Pharmaceuticals Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 48 overdue payments to 48 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 48)

SupplierAmount dueDue sinceReported on
Anand Packages
Aquatic Remedies Limited
Ipca Laboratories Limited
Prachin Chemical
an individual supplier

To see the full MSME payment records of Shine Pharmaceuticals Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Shine Pharmaceuticals Limited has a workforce of 780 employees on its EPFO records as of Mar 26, 2025, across 7 active EPFO establishments.

Employee count
780
Active EPFO establishments
7
Employee growth
4.84%

GST

Shine Pharmaceuticals has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
24AAECS2660M1Z7GujaratActive01 Jul 2017
19AAECS2660M1ZYWest BengalActive01 Jul 2017
20AAECS2660M1ZFJharkhandActive01 Jul 2017

To see the full GST registrations and return filing status of Shine Pharmaceuticals Limited, buy the company report.

Recent activity

Shine Pharmaceuticals Limited has 11 board changes on record since 1996: 6 appointments and 5 cessations. The latest: Tejal Ashish Parikh ceased to be Additional Director on 29 Sep 2024.

AGM
Shine Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Shine Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Tejal Ashish Parikh ceased to be Additional Director.
Appointed
Tejal Ashish Parikh was appointed as Director.
Charges
A charge registered on 24 Dec 2020 via Charge ID 100397788 with Others was fully satisfied on 21 Mar 2024.
Ceased
Rangoli Saurav Gada ceased to be Additional Director.
Appointed
Rangoli Saurav Gada was appointed as Director.
Charges
A charge registered on 26 Sep 2019 via Charge ID 100294266 with Others was fully satisfied on 30 Mar 2022.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100397788 was registered on 24 Dec 2020.
Charges
A charge with Others amounted to Rs. 0.75 Cr with Charge ID 100294266 was registered on 26 Sep 2019.
Ceased
Noel Bhattacharjee ceased to be Whole-Time Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100272741 was registered on 29 Jun 2019.

13 earlier events are in the company report.

Frequently asked questions

Shine Pharmaceuticals is an active public limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 1994 (32+ years old) and is registered under CIN U24231GJ1994PLC022787.

Shine Pharmaceuticals has 6 current directors:

The latest financial statements of Shine Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Shine Pharmaceuticals is 24AAECS2660M1Z7, registered in Gujarat. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 19AAECS2660M1ZY (West Bengal), 20AAECS2660M1ZF (Jharkhand).

The CIN (Corporate Identification Number) of Shine Pharmaceuticals is U24231GJ1994PLC022787. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Shine Pharmaceuticals has 14 court cases on record: 5 filed by the company and 9 filed against it. 7 are pending. Most are in the district courts.

Shine Pharmaceuticals was incorporated on 17 August 1994, making it 32+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Shine Pharmaceuticals has 2 deals on record (2 secondary share transfers); the latest was in August 2019.

The peers of Shine Pharmaceuticals by revenue are Aurochem Laboratories (India) Private Limited, Vartika Chemicals & Pharmaceuticals Private Limited, Ananta Medicare Limited, Amol Pharmaceuticals Private Limited, Alvita Pharma Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Tejal Ashish Parikh ceased to be Additional Director on 29 Sep 2024. Tejal Ashish Parikh was appointed as Director on 30 Mar 2024. Rangoli Saurav Gada ceased to be Additional Director on 29 Sep 2023. Shine Pharmaceuticals has 11 board changes on record in total.

Yes, Shine Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0074140).

Shine Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 48 overdue payments to 48 micro and small suppliers. The latest return was filed on 08 Jun 2019.